SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-228503
Filing Date
2012-05-11
Accepted
2012-05-11 16:28:13
Documents
3
Period of Report
2012-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d351359d8k.htm 8-K 12254
2 PRESS RELEASE d351359dex991.htm EX-99.1 34981
3 GRAPHIC g351359ex99_1logo.jpg GRAPHIC 8870
  Complete submission text file 0001193125-12-228503.txt   60830
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 12834952
SIC: 2834 Pharmaceutical Preparations